Product recall profile

TZIELD, teplizumab for injection, 2 mg per 2 mL (1 mg/mL) for intravenous infusion

Review 1 Canadian recall notice for TZIELD, teplizumab for injection, 2 mg per 2 mL (1 mg/mL) for intravenous infusion, including affected identifiers and…

Recall notices

Recalls linked to this product

Loading recalls...

Explore SafetyPulse

Continue exploring Canadian recalls